Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9–39) an antagonist of the receptor

B Thorens, A Porret, L Bühler, SP Deng, P Morel… - Diabetes, 1993 - Am Diabetes Assoc
B Thorens, A Porret, L Bühler, SP Deng, P Morel, C Widmann
Diabetes, 1993Am Diabetes Assoc
A complementary DNA for a glucagon-like peptide-1 receptor was isolated from a human
pancreatics islet cDNA library. The isolated clone encoded a protein with 90% identity to the
rat receptor. In stably transfected fibroblasts, the receptor bound [125I] GLP-1 with high
affinity (K d= 0.5 nM) and was coupled to adenylate cyclase as detected by a GLP-1-
dependent increase in cAMP production (EC50= 93 pM). Two peptides from the venom of
the lizard Heloderma suspectum, exendin-4 and exendin-(9–39), displayed similar ligand …
A complementary DNA for a glucagon-like peptide-1 receptor was isolated from a human pancreatics islet cDNA library. The isolated clone encoded a protein with 90% identity to the rat receptor. In stably transfected fibroblasts, the receptor bound [125I]GLP-1 with high affinity (Kd = 0.5 nM) and was coupled to adenylate cyclase as detected by a GLP-1-dependent increase in cAMP production (EC50 = 93 pM). Two peptides from the venom of the lizard Heloderma suspectum, exendin-4 and exendin-(9–39), displayed similar ligand binding affinities to the human GLP-1 receptor. Whereas exendin-4 acted as an agonist of the receptor, inducing cAMP formation, exendin-(9–39) was an antagonist of the receptor, inhibiting GLP-1–induced cAMP production. Because GLP-1 has been proposed as a potential agent for treatment of NIDDM, our present data will contribute to the characterization of the receptor binding site and the development of new agonists of this receptor.
Am Diabetes Assoc